Study to Compare the Efficacy and Safety of Administration of the Fix Dose Combination of Linagliptin Plus Metformin in Drug naïve Type 2 Patients
Clinical trial NCT01708902 · COMPLETED
Trial details
- NCT number
- NCT01708902
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-04-01
- Enrollment
- 876
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.